SCHEMBL5388613

SCHEMBL5388613

CCN(CC)c1ccc(N=Nc2c(Br)cc([N+](=O)[O-])cc2C#N)c(NC(C)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.39
HTT P42858 3/20 0.37
MAPT P10636 8/20 0.35
ALDH1A1 P00352 6/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
LMNA P02545 3/20 0.35
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
GRK2 P25098 1/20 0.34
DNMT1 P26358 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
GLA P06280 1/20 0.33
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
GFER P55789 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11222989 0.94 RECQL (0.41) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL29363175 0.94 RECQL (0.41) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL11223012 0.94 RECQL (0.41) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL9319844 0.92 LMNA (0.40) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL9319847 0.92 LMNA (0.40) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL29363120 0.92 LMNA (0.40) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL10943856 0.92 RECQL (0.36) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL622280 0.91 HTT (0.41) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL622281 0.91 HTT (0.41) RECQLHTTMAPTALDH1A1MEN1
SCHEMBL11695350 0.91 MAPT (0.36) RECQLHTTMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7301013-B2 Azo compounds CLARIANT FINANCE (BVI) LIMITED (GB) 2007-11-27 US disclosed
US-20060258854-A1 Azo compounds CLARIANT FINANCE (BVI) LIMITED 2006-11-16 US disclosed
US-7101983-B2 Azo dyes CLARIANT FINANCE (BVI) LIMITED (VG) 2006-09-05 US disclosed
EP-1466947-A1 AZO compound Clariant Finance (BVI) Limited (VG) 2004-10-13 EP disclosed
US-20040143108-A1 Azo dyes CLARIANT FINANCE (BVI) LIMITED (VG) 2004-07-22 US disclosed
EP-1377641-A1 AZO DYES Clariant Finance (BVI) Limited (VG) 2004-01-07 EP disclosed
WO-2002081572-A1 AZO DYES CLARIANT INTERNATIONAL LTD (CH) 2002-10-17 WO disclosed
US-4046757-A 2-Optionally substituted alkyl-and phenylsulfonylphenyl-azo-phenyl dyes and a process for their synthesis SANDOZ LTD. (CH) 1977-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258854-A1 Azo compounds CYP1B1, TYR, CYP1A1 RECQL 2000/4885HTT 2638/4885MAPT 748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.